Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Glenmark Pharmaceuticals receives 2nd ANDA tentative approval for Saxagliptin Tablets, 2.5 mg and 5 mg’.
The above information is a part of company’s filings submitted to BSE.